Since copies of the studied genes were found in only 2 % cases of laryngeal carcinoma, it can be concluded that SLC2A1 and SLC2A3 amplification does not affect the expression of GLUT1 and GLUT3 in this type of neoplasm. The gene discussed is SLC2A3; the disease is laryngeal carcinoma.